The Health Federation of Philadelphia provides training and technical support to address the range of knowledge and skills needed to identify, assess, and treat patients for opioid use disorder in Primary Care settings. This includes introducing the concept of medication assisted treatment to primary care teams, providing waiver training to primary care providers, and offering a range of support activities for providers to increase their skills and improve treatment delivery.
In 2020, the Philadelphia Department of Public Health (PDPH) is offering an incentive program to encourage providers to complete their buprenorphine waiver training as well as the MAT Preceptor Program in 2020. To support this program, the Health Federation of Philadelphia is planning waiver trainings and offering additional dates for the MAT Preceptor Program.
For more information about this program, eligibility, and how to apply, please refer to the following FAQ or contact Catherine Abrams at email@example.com.
All programs will be online until further notice.
For everyone on your team:
This is a great opportunity to learn from two exceptionally skilled educators, researchers and community health center providers regarding current trends in buprenorphine prescribing within an integrated primary and behavioral health and trauma informed framework.
"Primary Care for Opioid Use Disorder: Next Steps"
Friday, April 17, 2020
Dan Mullin, PsyD, MPH and Stephen Martin, MD, EdM
This program is accredited for CME, Nursing, and Social Work.
Registration is required at this link: https://www.eventbrite.com/e/primary-care-for-opioid-use-disorder-next-steps-tickets-94182681937
Buprenorphine Waiver trainings:
· 8 hour live Buprenorphine Waiver trainings. To register, send your preferred date (listed below) and your contact information to Rebecca Tantala at firstname.lastname@example.org
April 21, 2020 from 9:00 am to 5:00 pm
May 5, 2020 from 9:00 am to 5:00 pm
May 11, 2020 from 9:00 am to 5:00 pm
May 20, 2020 from 9:00 am to 5:00 pm
· Half and Half Waiver training on May 8, 2020 from 12:30 pm to 5:00 pm, register at the following link: https://www.eventbrite.com/e/half-and-half-mat-waiver-training-for-primary-care-providers-tickets-94415803209
MAT Preceptor Program is now online!
"Integrating Medications for Opioid Use Disorder into Primary Care"
Part A: Friday, April 3, 2020
Additional dates are scheduled for May 15, 2020 and June 25, 2020
8:30 am - 4:30 pm
Part B: Scheduled individually
Requirements: Registrants must have already completed their waiver training and submit their license, resume, and waiver certificate prior to receiving their observation dates.
CME is included.
Faculty includes: Jeffrey Hom, MD, MPH from PDPH, Lara Weinstein, MD, MPH, DrPH, Laura McNicholas, MD, Robin DeBates, LCSW, Mayetta McQueen, CRS, Kristianna Rubin, CRS and Manik Chhabra, MD. Please pass this along to those who might be interested:
About the MAT Preceptor Program:
Our mini-residency training offers content that is not covered in the buprenorphine waiver training for primary care providers who are seeking to refine their skills. Specific topics covered include diversion, continued substance use, benzodiazepine use, point of care testing, harm reduction and pain management. Cases will be presented to help participants discuss ways to address patient needs and discussion is encouraged. Our faculty is highly experienced and are eager to help others navigate buprenorphine prescribing.
Ongoing programs to support primary care practice:
· MAT Protocol Workshop, Friday, March 27, 2020 from 3:00 pm to 4:30 pm
Robin DeBates, LCSW, MSW - Consultant - Come to discuss work flow, developing buy in from other staff, etc and problem solve ways to support buprenorphine access in primary care sites.
· MAT Provider Collaborative, Friday, April 24, 2020 from 3:00 pm to 4:30 pm
This group is for waivered primary care providers to discuss practice issues related to treating OUD in primary care. We will invite a consultant to this meeting depending on the topics that the group wishes to discuss. Prior to COVID19. Sublocade and benzo tapering were topics of interest, however, we imagine that you might want to discuss telehealth at our next meeting. Let us know what you need so we invite the right consultant!
Request to join these groups by contacting Catherine Abrams at email@example.com